When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica FDA's Overreach on Compounded Peptides Is BPC 157 Legal? Understanding Its Status and Implications